Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -10,238 | -6,935 | -9,384 | -6,027 | -5,428 |
| Depreciation Amortization | 1,076 | 898 | 689 | 627 | 476 |
| Accounts receivable | 358 | 47 | -1,080 | 254 | -359 |
| Other Working Capital | 639 | -174 | 23 | 87 | 557 |
| Other Operating Activity | -246 | 10 | 1,157 | -213 | 423 |
| Operating Cash Flow | $-8,411 | $-6,154 | $-8,595 | $-5,272 | $-4,331 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 1,374 | 6,472 | 4,368 | 4,094 | -17,394 |
| PPE Investments | -221 | -336 | -403 | -419 | -72 |
| Net Acquisitions | N/A | N/A | -1,313 | N/A | N/A |
| Other Investing Activity | -666 | -209 | 0 | 0 | 0 |
| Investing Cash Flow | $487 | $5,927 | $2,652 | $3,675 | $-17,466 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 600 | 12,615 |
| Debt Repayment | -310 | -784 | -107 | -25 | -26 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -754 |
| Other Financing Activity | 9,299 | 266 | 32 | 33 | 17,508 |
| Financing Cash Flow | $8,989 | $-518 | $-75 | $608 | $29,343 |
| Exchange Rate Effect | -17 | 28 | 36 | N/A | N/A |
| Beginning Cash Position | 727 | 1,444 | 7,426 | 8,415 | 869 |
| End Cash Position | 1,775 | 727 | 1,444 | 7,426 | 8,415 |
| Net Cash Flow | $1,048 | $-717 | $-598 | $-989 | $7,546 |
| Free Cash Flow | |||||
| Operating Cash Flow | -8,411 | -6,154 | -8,595 | -5,272 | -4,331 |
| Capital Expenditure | -221 | -336 | -403 | -419 | -72 |
| Free Cash Flow | -8,632 | -6,490 | -8,998 | -5,691 | -4,403 |